UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000026961
Receipt No. R000030917
Scientific Title An Open label Phase I Study to Evaluate the Safety and Efficacy of OBP-301 with Pembrolizumab in Patients with advanced solid tumors.
Date of disclosure of the study information 2017/07/31
Last modified on 2018/11/29 11:41:08

No. Disposal Last modified on Item of update
1 Insert 2017/04/12 15:25:37
2 Update 2017/04/28 13:33:48 Date of disclosure of the study information
3 Update 2017/05/12 10:34:54 Date of disclosure of the study information
4 Update 2017/05/12 10:36:26 Date of protocol fixation
Anticipated trial start date
5 Update 2017/05/12 13:23:42 Key inclusion criteria
6 Update 2017/10/13 15:14:06 Recruitment status
Anticipated trial start date
7 Update 2017/10/13 15:15:09 Institutions
8 Update 2018/11/29 11:41:08 Interventions/Control_1
Interventions/Control_1


Contact us.